Cargando…
Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells
In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571264/ https://www.ncbi.nlm.nih.gov/pubmed/36235247 http://dx.doi.org/10.3390/molecules27196709 |
_version_ | 1784810321436737536 |
---|---|
author | Kishk, Safaa M. Eltamany, Enas E. Nafie, Mohamed S. Khinkar, Roaa M. Hareeri, Rawan H. Elhady, Sameh S. Yassen, Asmaa S. A. |
author_facet | Kishk, Safaa M. Eltamany, Enas E. Nafie, Mohamed S. Khinkar, Roaa M. Hareeri, Rawan H. Elhady, Sameh S. Yassen, Asmaa S. A. |
author_sort | Kishk, Safaa M. |
collection | PubMed |
description | In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle analysis, RT-PCR, DNA fragmentation, and Western blotting techniques. Cytotoxic results showed that compound (4) had a significant cytotoxic effect against HL60 cells (IC(50) = 8.09 µM), while compound (8b) had a noticeable activity against HepG2 cells (IC(50) = 13.14 µM). Compounds (4) and (8b) mediated their cytotoxicity via PI3K/AKT pathway inhibition. These results were assured by molecular docking studies. These results support further exploratory research focusing on the therapeutic activity of coumarin derivatives as cytotoxic agents. |
format | Online Article Text |
id | pubmed-9571264 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95712642022-10-17 Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells Kishk, Safaa M. Eltamany, Enas E. Nafie, Mohamed S. Khinkar, Roaa M. Hareeri, Rawan H. Elhady, Sameh S. Yassen, Asmaa S. A. Molecules Article In this study, a series of coumarin derivatives, either alone or as hybrids with cinnamic acid, were synthesized and evaluated for their cytotoxicity against a panel of cancer cells using the MTT assay. Then, the most active compounds were inspected for their mechanism of cytotoxicity by cell-cycle analysis, RT-PCR, DNA fragmentation, and Western blotting techniques. Cytotoxic results showed that compound (4) had a significant cytotoxic effect against HL60 cells (IC(50) = 8.09 µM), while compound (8b) had a noticeable activity against HepG2 cells (IC(50) = 13.14 µM). Compounds (4) and (8b) mediated their cytotoxicity via PI3K/AKT pathway inhibition. These results were assured by molecular docking studies. These results support further exploratory research focusing on the therapeutic activity of coumarin derivatives as cytotoxic agents. MDPI 2022-10-09 /pmc/articles/PMC9571264/ /pubmed/36235247 http://dx.doi.org/10.3390/molecules27196709 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kishk, Safaa M. Eltamany, Enas E. Nafie, Mohamed S. Khinkar, Roaa M. Hareeri, Rawan H. Elhady, Sameh S. Yassen, Asmaa S. A. Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells |
title | Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells |
title_full | Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells |
title_fullStr | Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells |
title_full_unstemmed | Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells |
title_short | Design and Synthesis of Coumarin Derivatives as Cytotoxic Agents through PI3K/AKT Signaling Pathway Inhibition in HL60 and HepG2 Cancer Cells |
title_sort | design and synthesis of coumarin derivatives as cytotoxic agents through pi3k/akt signaling pathway inhibition in hl60 and hepg2 cancer cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9571264/ https://www.ncbi.nlm.nih.gov/pubmed/36235247 http://dx.doi.org/10.3390/molecules27196709 |
work_keys_str_mv | AT kishksafaam designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells AT eltamanyenase designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells AT nafiemohameds designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells AT khinkarroaam designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells AT hareerirawanh designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells AT elhadysamehs designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells AT yassenasmaasa designandsynthesisofcoumarinderivativesascytotoxicagentsthroughpi3kaktsignalingpathwayinhibitioninhl60andhepg2cancercells |